ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

No Pathway Network information available for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Pathways in the ncRNAs involved in STAT3 signaling in hepatocellular carcinoma SuperPath

#	Name	Source	Genes
1	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	WikiPathways	IL11 IL11RA IL6 IL6R IL6ST JAK1 JAK2 JAK3 MIR200A MIR200B MIR200C MIR21 NFKB1 RELA SOX4 STAT3 UCA1 ZEB1 (see all 18) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	UCA1	Urothelial Cancer Associated 1	RNA Gene	1
2	ZEB1	Zinc Finger E-Box Binding Homeobox 1	Protein Coding	1
3	STAT3	Signal Transducer And Activator Of Transcription 3	Protein Coding	1
4	SOX4	SRY-Box Transcription Factor 4	Protein Coding	1
5	RELA	RELA Proto-Oncogene, NF-KB Subunit	Protein Coding	1
6	NFKB1	Nuclear Factor Kappa B Subunit 1	Protein Coding	1
7	MIR21	MicroRNA 21	RNA Gene	1
8	MIR200C	MicroRNA 200c	RNA Gene	1
9	MIR200B	MicroRNA 200b	RNA Gene	1
10	MIR200A	MicroRNA 200a	RNA Gene	1
11	JAK3	Janus Kinase 3	Protein Coding	1
12	JAK2	Janus Kinase 2	Protein Coding	1
13	JAK1	Janus Kinase 1	Protein Coding	1
14	IL11RA	Interleukin 11 Receptor Subunit Alpha	Protein Coding	1
15	IL11	Interleukin 11	Protein Coding	1
16	IL6ST	Interleukin 6 Cytokine Family Signal Transducer	Protein Coding	1
17	IL6R	Interleukin 6 Receptor	Protein Coding	1
18	IL6	Interleukin 6	Protein Coding	1

Disorders associated with ncRNAs involved in STAT3 signaling in hepatocellular carcinoma SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Breast implant-associated anaplastic large cell lymphoma	Enrichment	JAK1, JAK2, STAT3	8.71
2	Craniosynostosis and dental anomalies	Enrichment	IL11RA	2.88
3	Intellectual developmental disorder with speech delay and dysmorphic facies	Enrichment	SOX4	2.88
4	Stuve-wiedemann syndrome 2	Enrichment	IL6ST	2.88
5	Hyper-ige syndrome 4a, autosomal dominant, with recurrent infections	Enrichment	IL6ST	2.88
6	T-cell large granular lymphocyte leukemia	Enrichment	STAT3	2.88
7	Interleukin 6, serum level of, quantitative trait locus	Enrichment	IL6R	2.88
8	Soluble interleukin-6 receptor, serum level of, quantitative trait locus	Enrichment	IL6R	2.88
9	Hyper-ige syndrome 5, autosomal recessive, with recurrent infections	Enrichment	IL6R	2.88
10	Autoimmune disease, multisystem, infantile-onset, 1	Enrichment	STAT3	2.88
11	Hyper-ige syndrome 4b, autosomal recessive, with recurrent infections	Enrichment	IL6ST	2.88
12	Immunodeficiency 94 with autoinflammation and dysmorphic facies	Enrichment	IL6ST	2.88
13	T-b+ severe combined immunodeficiency due to jak3 deficiency	Enrichment	JAK3	2.88
14	Stat3-related early-onset multisystem autoimmune disease	Enrichment	STAT3	2.88
15	Chronic lymphoproliferative disorder of natural killer cells	Enrichment	STAT3	2.88
16	Mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiency	Enrichment	JAK1	2.88
17	Immunodeficiency, common variable, 12, with autoimmunity	Enrichment	NFKB1	2.58
18	Thrombocythemia 3	Enrichment	JAK2	2.58
19	Autoinflammatory disease, familial, behcet-like 3	Enrichment	RELA	2.58
20	Rela fusion-positive ependymoma	Enrichment	RELA	2.58
21	Autoinflammation, immune dysregulation, and eosinophilia	Enrichment	JAK1	2.58
22	Polycythemia	Enrichment	JAK2	2.58
23	Hypereosinophilic syndrome	Enrichment	JAK2	2.58
24	Common variable immunodeficiency 12	Enrichment	NFKB1	2.58
25	Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency	Enrichment	JAK3	2.40
26	Hyper-ige syndrome 1, autosomal dominant, with recurrent infections	Enrichment	STAT3	2.40
27	Polycythemia vera	Enrichment	JAK2	2.40
28	Stuve-wiedemann syndrome 1	Enrichment	IL6ST	2.40
29	Corneal dystrophy, posterior polymorphous, 3	Enrichment	ZEB1	2.40
30	Corneal dystrophy, fuchs endothelial, 6	Enrichment	ZEB1	2.40
31	Hyper ige syndrome	Enrichment	STAT3	2.40
32	Intraocular pressure quantitative trait locus	Enrichment	ZEB1	2.40
33	Stüve-wiedemann syndrome	Enrichment	IL6ST	2.40
34	Kaposi sarcoma	Enrichment	IL6	2.28
35	Erythrocytosis, familial, 1	Enrichment	JAK2	2.28
36	Budd-chiari syndrome	Enrichment	JAK2	2.28
37	Corneal dystrophy	Enrichment	ZEB1	2.28
38	Adenosine deaminase deficiency	Enrichment	JAK3	2.28
39	Systemic-onset juvenile idiopathic arthritis	Enrichment	IL6	2.28
40	Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative	Enrichment	JAK3	2.18
41	Rheumatoid arthritis, systemic juvenile	Enrichment	IL6	2.18
42	Fuchs' endothelial dystrophy	Enrichment	ZEB1	2.18
43	Myeloproliferative neoplasm	Enrichment	JAK2	2.18
44	Corneal dystrophy, posterior polymorphous, 1	Enrichment	ZEB1	2.10
45	Type 1 diabetes mellitus	Enrichment	IL6	2.10
46	Myelofibrosis	Enrichment	JAK2	2.03
47	Essential thrombocythemia	Enrichment	JAK2	2.03
48	Common variable immunodeficiency	Enrichment	NFKB1	2.03
49	Permanent neonatal diabetes mellitus	Enrichment	STAT3	1.98
50	Inflammatory bowel disease 1	Enrichment	IL6	1.93
51	Leukemia, acute lymphoblastic 3	Enrichment	JAK2	1.93
52	Ciliary dyskinesia, primary, 3	Enrichment	NFKB1	1.88
53	Acute promyelocytic leukemia	Enrichment	STAT3	1.77
54	Nk-cell enteropathy	Enrichment	JAK3	1.77
55	Coffin-siris syndrome 1	Enrichment	SOX4	1.70
56	Arteriovenous malformations of the brain	Enrichment	IL6	1.60
57	Diffuse large b-cell lymphoma	Enrichment	STAT3	1.60
58	Craniosynostosis	Enrichment	IL11RA	1.58
59	Severe covid-19	Enrichment	JAK3	1.42
60	Severe combined immunodeficiency	Enrichment	JAK3	1.37
61	Leukemia, acute myeloid	Enrichment	JAK2	1.29
62	Type 2 diabetes mellitus	Enrichment	IL6	1.27
63	Primary ovarian insufficiency	Enrichment	JAK2	1.12

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Pathway Network for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Member Pathways for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Pathways in the ncRNAs involved in STAT3 signaling in hepatocellular carcinoma SuperPath

Associated Genes for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Associated Disorders for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Disorders associated with ncRNAs involved in STAT3 signaling in hepatocellular carcinoma SuperPath

STRING Interaction Network for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma

Sources for ncRNAs involved in STAT3 signaling in hepatocellular carcinoma